Effects of antiepileptic drugs on cognition

Epilepsia

Volumn 42, Issue SUPPL. 1, 2001, Pages 46-49

  Aldenkamp, Albert P ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AMNESIA; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DRUG EFFECT; EPILEPSY; HUMAN; INTELLIGENCE TEST; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER;

EID: 0035010872     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.00516.x     Document Type: Conference Paper

References (44)

1. Ideström CM, Schalling D, Carlquist U, et al. Behavioral and psychological studies: acute effects of diphenylhydantoin in relation to plasma levels. Psychol Med 1972;2:111-20.
2. Dodrill CB, Troupin AS. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 1977;27:1023-8.
3. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.
4. MacLeod CM, Dekahan AS, Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 1978;202:1102-4.
5. Smith WL, Lowrey JB. Effects of diphenylhydantoin on mental abilities in the elderly. J Am Geriatr Soc 1975;23:207-11.
6. Thompson PJ, Huppert F, Trimble MR. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand 1980;S80:75-80.
7. Thompson PJ, Huppert FA, Trimble MR. Phenytoin and cognitive functions: effects on normal volunteers and implications for epilepsy. Br J Clin Psychol 1981;20:155-62.
8. Meador KJM, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41:1537-40.
9. Meador KJM, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34:153-7.
10. Aldenkamp AP, Alpherts WCJ, Blennow G. et al. Withdrawal of antiepileptic medication: effects on cognitive function in children: the results of the multicentre "Holmfrid" study. Neurology 1993; 43:41-51.
11. Thompson PJ, Trimble MR. Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol 1981;12:819-24.
12. Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994;35:381-90.
13. Prevey ML, Delaney RC, Cramer JA, et al. Effect of Valproate on cognitive function: comparison with carbamazepine: the Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53:1008-16.
14. Vining EP, Mellitis ED, Dorsen MM, et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-74.
15. Calandre EP, Dominguez-Granados R, Gomez-Rubio M, et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990;81:504-6.
16. Meador KJM, Loring DW, Huh K, et al. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-4.
17. Gallassi R, Morreale A, Di Sarro R, et al. Cognitive effects of antiepileptic drug discontinuation. Epilepsia 1992;33(suppl 6): 41-4.
18. Forsythe I, Butler R, Berg I, et al. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991;33:524-34.
19. Stevens JH, Schaffer JW, Brown CC. A controlled comparison of the effect of diphenylhydantoin and placebo on mood and psychomotor functioning in normal volunteers. J Clin Pharmacol 1974: 14:543-51.
20. Amman MG, Werry JS, Paxton JW, et al. Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration and diagnosis. Epilepsia 1987; 28:115-24.
21. Read CL, Stephe LJ, Stolarek IH, et al. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study. Seizure 1998;7:159-62.
22. Herranz JL, Arteaga R, Armijo JA. Side effects of sodium valproate in monotherapy controlled by plasma levels. Epilepsia 1982; 23:203-14.
23. Brouwer OF, Pieters MSM, Bakker AM, et al. Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performance. Epilepsy Res 1992;13:245-53.
24. Amman MG, Werry JS, Paxton JW, et al. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type and time of medication. Epilepsia 1990;31:51-60.
25. Aldenkamp AP, Alpherts WCJ, Moerland MC, et al. Controlled release carbamazepine: cognitive side-effects in patients with epilepsy. Epilepsia 1987;28:507-14.
26. Aldenkamp AP, Rentmeester TH, Hulsman J, et al. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates. Eur J Clin Pharmacol 1998;54:185-92.
27. Aldenkamp AP, Trimble MR. Cognitive side-effects of antiepileptic drugs: fact or fiction? Epilepsia 1996;37(suppl 4):82.
28. Riekkinen PJ, Kalvianinen R, Aikia M, et al. Cognitive and electrophysiological effects of vigabatrin and carbamazepine. Epilepsia 1990;31:620.
29. Mervaala E, Partanen J, Nousiainen U, et al. Electrophysiological effects of gamma-vinyl GABA and carbamazepine. Epilepsia 1989;30:189-93.
30. Aldenkamp AP, Vermeulen J, Mulder OG, et al. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Epilepsia 1994;35: 999-1004.
31. Aldenkamp AP, Mulder OG, Overweg J. Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy. J Epilepsy 1997;10:117-21.
32. Marciani MG, Stanzione P, Mattia D, et al. Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neurophysiol 1998;21:41-7.
33. Meador KJ, Baker GA. Behavioral and cognitive effects of lamotrigine. J Child Nenrol 1997:12(suppl 1):44-7.
34. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999;52:321-7.
35. Aikiae M, Kaelviaeinen R, Sivenius J, et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199-203.
36. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529-33.
37. Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997;48:1025-31.
38. Kalviainen R, Aikia, M., Mervaala E, et al. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 1996;25:291-7.
39. Leach JP, Girvan J, Paul A, et al. Gabapentin and cognition: a double blind, dose-ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62:372-6.
40. Mortimore C, Trimble M, Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998;7:359-64.
41. Meador KJ. Assessing cognitive effects of a new AED without the bias of practice effects. Epilepsia 1997;38(suppl 3):60.
42. Aldenkamp AP, Baker G, Mulder OG, et al. A randomized observer-blind clinical study comparing the cognitive effects of topiramate versus valproate in a first-line add-on design. Epilepsia 1998;39(suppl 6):188-9.
43. Aldenkamp AP. The cognitive profile of the experimental antiepileptic drug CGP 33.101. Basel: Presentation at the Final Investigators Meeting, March 14, 1996.
44. Neijens LGJ, Alpherts WCJ, Aldenkamp AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Progr Neuropsychopharmacol Biol Psychiatry 1995;19: 411-9.